A specified sildenafil/tadalafil combination with unusually clear public dose-count pricing. Its sublingual timing claims require a different evidence standard from ordinary tablet research.

Sparks lists sildenafil 55 mg and tadalafil 22 mg in a dissolving preparation. Those numbers identify the product; they are not interchangeable with the milligram amounts in MAX, a Hard Mint or an ordinary tadalafil tablet. A comparison that calls all three “the same combination” misses the strength and delivery differences.

Two drugs, one fixed formulation

The practical attraction is a single product containing two ED medicines. The corresponding limitation is less separation between the components if response or side effects lead the clinician to reconsider one of them. This is a prescribing question before it is a convenience question.

The documented product is a fixed 55 mg sildenafil / 22 mg tadalafil sublingual preparation. The listed delivery format is compounded sublingual drop. FDA does not approve compounded finished products or verify their safety, effectiveness and quality before marketing. A licensed prescriber and pharmacy do not turn the compound into an FDA-approved product. FDA: Compounding and the FDA — questions and answers

Product
Ro Sparks
Provider
Ro
Listed ingredients
Sildenafil + tadalafil
Format
Compounded sublingual drop

What the advertised price actually buys

The catalog shows four through ten doses, while the dedicated Sparks page also describes plans up to fourteen doses for $168 monthly. Those are different levels of catalog detail, not grounds to assume every account sees every quantity. Confirm the selected supply and any quarterly commitment.

Keep four numbers together: the amount due now, the quantity supplied, the period covered and the next renewal total. A monthly equivalent can make a prepaid plan look like a monthly bill. A low unit price can require a larger purchase. Neither figure tells you how often a medicine should be taken; only the prescription supplies those directions.

Monthly quantities
4, 6, 8 or 10 allocated doses
Monthly charges
$48, $72, $96 or $120 respectively
Unit arithmetic
$12 per allocated dose; not a prescribed frequency
Timing limitation
Advertised onset is measured after dissolution, not necessarily from placement in the mouth
Dedicated product page
Also describes 14 monthly doses for $168; confirm selected plan

What is supported—and what remains open

Ro’s onset wording starts its timing after the drop dissolves. A stopwatch starting when the product enters the mouth is measuring something else. The tadalafil/sildenafil study discussed here used daily tadalafil plus as-needed sildenafil, not this fixed sublingual dose, so it cannot validate the Sparks onset headline.

The evidence basis identified for this review is a 180-man trial of daily tadalafil plus as-needed sildenafil, not the Sparks sublingual formula. The remaining uncertainty concerns controlled finished-product onset and comparative safety. This distinction matters because a study can differ in strength, route, schedule, patient group or the outcome measured. A favorable result for one ingredient or regimen is not a clinical result for every product that shares its name.

Our review uses product and policy documents for commercial facts, and labels, government information and primary research for the medical context. We did not purchase or personally test this treatment, measure response times, or audit the provider’s clinical decisions. A missing matched study in this review is an evidence limit, not proof that a product never helps anyone.

The safety discussion this formula needs

PDE5 medicines can cause a dangerous blood-pressure drop with nitrates or nitrites, including recreational “poppers,” and must not be combined with riociguat. Tell the prescriber about all medicines, supplements, blood-pressure problems and heart conditions. Do not add another ED medicine or increase an amount based on an advertisement or this review. MedlinePlus: Sildenafil MedlinePlus: Tadalafil

Headache, flushing, indigestion, congestion and dizziness are among the adverse effects described for these medicines. The exact risk depends on the drug, prescription and medical history. A short list here cannot replace the complete pharmacy information or an individual assessment.

Overlapping ED medicines
The tadalafil label advises against use with other PDE5 inhibitors because combination safety and efficacy have not been established in labeling. A prescribed compound does not remove that uncertainty. DailyMed: Tadalafil prescribing information, including section 5.11

What the public listing does not settle

Ro Sparks is classified here as “publicly listed.” Public product listing; individual eligibility and current prescription require confirmation. A page being online does not verify shipping to every state, current stock, eligibility, or the formula that will be dispensed to a particular patient.

Ask how the clinician distinguishes an inadequate response to a single medicine from a timing, stimulation, tolerability or underlying-health issue before escalating to a combination.

Verify before ordering
Exact product name; complete ingredients and strengths; dispensing pharmacy; state access; clinician approval
Practical distinction
A safety document can describe an older formulation without confirming a current new-customer offer.

Refills, changes and cancellation

Ro distinguishes an order already moving through the pharmacy from future subscription shipments. The cancellation article advises contacting support promptly during processing and says an order cannot be canceled after shipment. The refund policy generally treats prescription orders as final, with separate handling for matters such as dispensing errors. We did not verify one universal ED cancellation cutoff. In particular, a deadline written for Ro Body should not be applied to an ED plan without confirmation. Keep the next ED order date and the instructions shown in that account.

A customer-service action changes an account; a prescribing decision changes treatment. Keep both confirmations when changing plans. If symptoms or adverse effects require attention, contact the clinical team rather than waiting for the next scheduled billing event. Ro Support: canceling an order · Ro Support: return and refund policy · Ro: terms of use, payments and subscriptions · Ro Support: changing your prescription

Compare the products that differ in a meaningful way

A useful next comparison for Ro Sparks changes one identifiable feature: the ingredient combination, the dosage form, the schedule or the provider’s commercial terms. The related reviews below make those differences visible. They are not a clinical ranking or a recommendation to substitute medicines.

Use the comparison desk to place up to three fact sheets together. The plan-cost guide explains why comparing a monthly equivalent with a per-dose headline can produce the wrong conclusion.

Questions to take to the consultation

Why is this combination appropriate after reviewing my response to a single medicine?

Also ask what would count as a useful response, what side effects should prompt contact, who reviews an unsatisfactory result, and how a change reaches the pharmacy before the next order. Keep the answer tied to this exact prescription, not the provider’s product family.

Prescription question
Why this ingredient list, strength, route and schedule for the symptoms discussed?
Payment question
What is charged today, what renews, and when does cancellation need to be recorded?
Follow-up question
How do I reach a clinician, and what should be handled through urgent or emergency care?

When account support is not enough

Seek emergency care for an erection lasting more than four hours or chest pain. Tell the treating team which medicines were taken and when. Sudden loss of vision or hearing needs prompt medical attention; do not wait for a routine subscription-support reply. MedlinePlus: Sildenafil MedlinePlus: Tadalafil

Read the underlying material

Sources & evidence notes

Provider documents support product and commercial details. Clinical references have their own study or labeling limits. Accessed October 7, 2026; indexed abstracts were used for the listed studies.

  1. Ro: ED product catalog and plan quantities

    Provider catalog; individual products, strengths and plan prices

  2. Ro: terms of use, payments and subscriptions

    Provider policy; distinguish general subscription terms from Ro Body terms

  3. Ro Support: canceling an order

    Provider support; processing orders and future shipments

  4. Ro Support: return and refund policy

    Provider support; prescription return and refund restrictions

  5. Ro Support: changing your prescription

    Provider support; clinical changes and follow-up

  6. EAU: Management of erectile dysfunction

    Specialty guideline; clinical evaluation, treatment, and limited combination evidence

  7. Cui et al. (2015): daily tadalafil with as-needed sildenafil

    Primary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI

  8. Ro: medication pricing

    Provider source; advertised plan prices and quantities

  9. Ro: Sparks product details

    Provider source; compounded formula, subscription pricing, and care process

  10. NIDDK: Diagnosis of erectile dysfunction

    Government patient information

  11. MedlinePlus: Tadalafil

    Drug information; standard tadalafil products

  12. DailyMed: Tadalafil prescribing information, including section 5.11

    Prescribing label; not evidence for the 4Play combination

  13. FDA: Compounding and the FDA — questions and answers

    Government guidance on compounded medications

  14. MedlinePlus: Sildenafil

    Drug information; standard sildenafil products